Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 69.53

-1.0%

Nov 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2568)	8/28/2009 2:23:16 PM
From: Jibacoa	Read Replies (1) of 3722

TRBN was up 76.2% and it is still up 45.95% at present.<g> Volume of 276,400 is about 23x its ADV. The stock opened with a good UG and traded above its Jul28 H of $4.23 bigcharts.marketwatch.com It announced an agreement with FACET for the joint worldwide development and commercialization of TRU-016, which is on a PI for CLL. TRBN will receive an upfront payment of $20M and may receive up to $176.5M in additional contingent payments.Facet will also purchase 2,243,649 shares of a newly issued TBRN common stock for an aggregate purchase price of $10M.<g>(The companies will share equally the costs of all development, commercialization and promotional activities and all global operating profits.) The stock is trying to get off from the DT coming from its March 2008 H at $12.60 bigcharts.marketwatch.com TRBN longer term resistance remains at the !5 to its Feb2007 all time H of $22.50 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next